T1	Participants 59 84	breast lymphoscintigraphy
T2	Participants 276 306	patients with breast carcinoma
T3	Participants 418 443	breast lymphoscintigraphy
T4	Participants 648 680	pain experienced by the patients
T5	Participants 939 1009	control group and experimental group of female breast cancer patients.
T6	Participants 2157 2182	breast lymphoscintigraphy
